Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley P Jones

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
BMC Rheumatology|March 20, 2019
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)Athimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.
Clinical and Experimental Dermatology|July 9, 2025
Methotrexate and ciclosporin both reduce levels of circulating IL-4 and IL-13 expressing CD4+ memory T-cells in childhood atopic dermatitisAnton Olsson, Kathryn Steel, Rachael Cooper, et al.
Scientific Reports|February 6, 2020
A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosisStephen J McWilliam, Anna Rosala-Hallas, Ashley P Jones, et al.
The Lancet. Respiratory Medicine|October 2, 2020
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trialSimon C Langton Hewer, Alan R Smyth, Michaela Brown, et al.
Scientific Reports|March 11, 2020
Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosisStephen J McWilliam, Anna Rosala-Hallas, Ashley P Jones, et al.
BMJ Open|July 4, 2024
HAP-FAST: a feasibility study incorporating qualitative, mechanistic and costing sub-studies alongside a randomised pilot trial comparing chest x-ray to low-dose CT scan and empirical antibiotics to antibiotics guided by the BIOFIRE® FILM ARRAY® pneumonia <i>plus</i> panel in adults with suspected non-ventilator-associated hospital-cquired pneumoniaNatalia Shafiqa, Stephen Aston, Alex Howard, et al.
The Lancet. Rheumatology|April 14, 2020
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trialAthimalaipet V Ramanan, Andrew D Dick, Catherine Guly, et al.
The British Journal of Dermatology|September 16, 2024
Methotrexate versus ciclosporin in the treatment of severe atopic eczema in children: an economic evaluationTracey H Sach, Kaitlyn R Chan, Ashley P Jones, et al.
Pilot and Feasibility Studies|December 15, 2016
Assessing the feasibility of injectable growth-promoting therapy in Crohn's diseaseMabrouka A Altowati, Ashley P Jones, Helen Hickey, et al.
BMJ Paediatrics Open|November 2, 2020
National survey of feasibility of NIV trials for management of children with bronchiolitisAnna Rosala-Hallas, Ashley P Jones, Emma Bedson, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
BMC Rheumatology|March 20, 2019
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)Athimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.
Clinical and Experimental Dermatology|July 9, 2025
Methotrexate and ciclosporin both reduce levels of circulating IL-4 and IL-13 expressing CD4+ memory T-cells in childhood atopic dermatitisAnton Olsson, Kathryn Steel, Rachael Cooper, et al.
Scientific Reports|February 6, 2020
A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosisStephen J McWilliam, Anna Rosala-Hallas, Ashley P Jones, et al.
The Lancet. Respiratory Medicine|October 2, 2020
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trialSimon C Langton Hewer, Alan R Smyth, Michaela Brown, et al.
Scientific Reports|March 11, 2020
Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosisStephen J McWilliam, Anna Rosala-Hallas, Ashley P Jones, et al.
BMJ Open|July 4, 2024
HAP-FAST: a feasibility study incorporating qualitative, mechanistic and costing sub-studies alongside a randomised pilot trial comparing chest x-ray to low-dose CT scan and empirical antibiotics to antibiotics guided by the BIOFIRE® FILM ARRAY® pneumonia <i>plus</i> panel in adults with suspected non-ventilator-associated hospital-cquired pneumoniaNatalia Shafiqa, Stephen Aston, Alex Howard, et al.
The Lancet. Rheumatology|April 14, 2020
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trialAthimalaipet V Ramanan, Andrew D Dick, Catherine Guly, et al.
The British Journal of Dermatology|September 16, 2024
Methotrexate versus ciclosporin in the treatment of severe atopic eczema in children: an economic evaluationTracey H Sach, Kaitlyn R Chan, Ashley P Jones, et al.
Pilot and Feasibility Studies|December 15, 2016
Assessing the feasibility of injectable growth-promoting therapy in Crohn's diseaseMabrouka A Altowati, Ashley P Jones, Helen Hickey, et al.
BMJ Paediatrics Open|November 2, 2020
National survey of feasibility of NIV trials for management of children with bronchiolitisAnna Rosala-Hallas, Ashley P Jones, Emma Bedson, et al.
Pageof 4